Cufsniff AM Drop is a specially formulated combination medication designed to relieve respiratory conditions associated with cough and congestion. Each 1 mL dose contains 7.5 mg of ambroxol, 12.5 mg of guaifenesin, and 0.25 mg of terbutaline, working synergistically to provide effective symptom relief.
Ambroxol is a mucolytic agent that helps to thin and loosen mucus in the airways, facilitating easier breathing. It promotes the clearance of secretions and aids in alleviating cough, making it particularly useful for individuals suffering from conditions like bronchitis and other respiratory infections.
Guaifenesin is an expectorant that assists in expelling mucus from the respiratory tract. By increasing the volume and reducing the viscosity of respiratory secretions, it helps to clear congestion, improving overall lung function and comfort.
Terbutaline, a bronchodilator, relaxes the muscles in the airways, resulting in widened air passages. This can relieve symptoms of wheezing and shortness of breath, making it a valuable component for those with asthma or chronic obstructive pulmonary disease (COPD).
Cufsniff AM Drop is indicated for the management of productive coughs and airway obstruction due to mucus accumulation. It provides a comprehensive approach to relieve symptoms associated with respiratory tract infections, enhancing the quality of life for those affected.